Examining heterogeneity in treatment response in clinical trials: Use of factor mixture models
View Presentation *Donald E Stull, United BioSource Corporation Keywords: clinicl trials, treatment response, mixture models Heterogeneity in treatment response is often encountered in clinical research outside the context of pre-defined subgroups. Analytic methods are now available to identify individuals who are more or less responsive to treatment in clinical trials and observational studies. Factor mixture model (FMM) methodology, is designed for data that exhibits heterogeneity in the overall sample but may include several latent subclasses that are themselves homogeneous. FMM combines latent class analysis and common factor analysis. These individuals, once identified, can then be assessed to see if they have common characteristics that may shed light on their differential response to treatment. Identifying heterogeneity in treatment response may play a key role in the development of truly “personalized medicine.”
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC